Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ataxin-2 (Homo sapiens (Human)) | BDBM258580![]() (US10633384, Example 12.42 | US9493486, 12.42) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258575![]() (US10633384, Example 12.37 | US9493486, 12.37) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258585![]() (US10633384, 13.01 | US9493486, 13.01) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258501![]() (US10633384, Example 1.23 | US9493486, 1.23) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM440743![]() ((?)-2-Fluoro-4-(trifluoromethoxy)benzyl 2-(4,5,6,7...) | UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258581![]() (US10633384, Example 12.43 | US9493486, 12.43) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258574![]() (US10633384, Example 12.36 | US9493486, 12.36) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258579![]() (US10633384, Example 12.41 | US9493486, 12.41) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258578![]() (US10633384, Example 12.40 | US9493486, 12.40) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258576![]() (US10633384, Example 12.38 | US9493486, 12.38) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258584![]() (US10633384, Example 13 | US9493486, 13) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258573![]() (US10633384, Example 12.35 | US9493486, 12.35) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258577![]() (US10633384, Example 12.39 | US9493486, 12.39) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258510![]() (US10633384, Example 3 | US9493486, 3) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258508![]() (BDBM258518 | US10633384, Example 5 | US9493486, 2....) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258582![]() (US10633384, Example 12.44 | US9493486, 12.44) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258504![]() (US10633384, Example 1.26 | US9493486, 1.26) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258591![]() (BDBM440745 | US9493486, 16B) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258572![]() (US10633384, Example 12.34 | US9493486, 12.34) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258502![]() (US10633384, Example 1.24 | US9493486, 1.24) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258571![]() (US10633384, Example 12.33 | US9493486, 12.33) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258509![]() (US10633384, Example 2.2 | US9493486, 2.2) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258500![]() (US10633384, Example 1.22 | US9493486, 1.22) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258479![]() (US10633384, Example 1 | US9493486, 1) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM440742![]() ((?)-2-Fluoro-4-(trifluoromethoxy)benzyl 2-(4,5,6,7...) | UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258542![]() (US10633384, Example 12.04 | US9493486, 12.04) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258514![]() (US10633384, Example 3.4 | US9493486, 3.4) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258515![]() (US10633384, Example 3.5 | US9493486, 3.5) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258555![]() (US10633384, Example 12.17 | US9493486, 12.17) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258569![]() (US10633384, Example 12.31 | US9493486, 12.31) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258525![]() (US10633384, Example 6.4 | US9493486, 6.4) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258586![]() (US10633384, Example 14 | US9493486, 14) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258521![]() (US10633384, Example 6 | US9493486, 6) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258507![]() (US10633384, Example 2 | US9493486, 2) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258520![]() (US10633384, Example 5.2 | US9493486, 5.2) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 26.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258491![]() (US10633384, Example 1.12 | US9493486, 1.12) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258553![]() (US10633384, Example 12.15 | US9493486, 12.15) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM440662![]() (US10633384, Example 2.1) | UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258583![]() (US10633384, Example 12.45 | US9493486, 12.45) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258497![]() (US10633384, Example 1.19 | US9493486, 1.19) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 39.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258505![]() (US10633384, Example 1.27 | US9493486, 1.27) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258587![]() (US10633384, 14.01 | US9493486, 14.01) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 41.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258532![]() (US10633384, Example 7 | US9493486, 7) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258570![]() (US10633384, Example 12.32 | US9493486, 12.32) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258540![]() (US10633384, Example 12.02 | US9493486, 12.02) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258488![]() (US10633384, Example 1.09 | US9493486, 1.09) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 50.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258564![]() (US10633384, Example 12.26 | US9493486, 12.26) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258556![]() (US10633384, Example 12.18 | US9493486, 12.18) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 53.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258513![]() (US10633384, Example 3.3 | US9493486, 3.3) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258519![]() (US10633384, Example 5.1 | US9493486, 5.1) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258494![]() (US10633384, Example 1.15 | US9493486, 1.15) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 64.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258516![]() (US10633384, Example 3.6 | US9493486, 3.6) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258567![]() (US10633384, Example 12.29 | US9493486, 12.29) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 68.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM440647![]() (US10633384, Example 1.14) | UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | 73.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258503![]() (US10633384, Example 1.25 | US9493486, 1.25) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258529![]() (US10633384, Example 6.8 | US9493486, 6.8) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 91 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258563![]() (US10633384, Example 12.25 | US9493486, 12.25) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258589![]() (BDBM440744 | US9493486, 16A) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258485![]() (US10633384, Example 1.06 | US9493486, 1.06) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258506![]() (US10633384, Example 1.28 | US9493486, 1.28) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258483![]() (US10633384, Example 1.04 | US9493486, 1.04) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 115 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258498![]() (US10633384, Example 1.20 | US9493486, 1.20) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258530![]() (US10633384, Example 6.9 | US9493486, 6.9) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 128 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258481![]() (US10633384, Example 1.02 | US9493486, 1.02) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 129 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258538![]() (US10633384, Example 12 | US9493486, 12) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258566![]() (US10633384, Example 12.28 | US9493486, 12.28) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 138 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258565![]() (US10633384, Example 12.27 | US9493486, 12.27) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258539![]() (US10633384, Example 12.01 | US9493486, 12.01) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258490![]() (US10633384, Example 1.11 | US9493486, 1.11) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 155 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258549![]() (US10633384, Example 12.11 | US9493486, 12.11) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 168 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258534![]() (US10633384, Example 8 | US9493486, 8) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 178 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258482![]() (US10633384, Example 1.03 | US9493486, 1.03) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 201 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258562![]() (US10633384, Example 12.24 | US9493486, 12.24) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 229 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258533![]() (US10633384, Example 7.1 | US9493486, 7.1) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258552![]() (US10633384, Example 12.14 | US9493486, 12.14) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258548![]() (US10633384, Example 12.10 | US9493486, 12.10) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258512![]() (US10633384, Example 3.2 | US9493486, 3.2) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 298 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258523![]() (US10633384, Example 6.2 | US9493486, 6.2) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 298 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258550![]() (US10633384, Example 12.12 | US9493486, 12.12) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 332 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258522![]() (US10633384, Example 6.1 | US9493486, 6.1) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 362 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258545![]() (US10633384, Example 12.07 | US9493486, 12.07) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 378 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258560![]() (US10633384, Example 12.22 | US9493486, 12.22) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 439 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258554![]() (US10633384, Example 12.16 | US9493486, 12.16) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 457 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258517![]() (US10633384, Example 4 | US9493486, 4) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 546 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258527![]() (US10633384, Example 6.6 | US9493486, 6.6) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 605 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258541![]() (US10633384, Example 12.03 | US9493486, 12.03) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 622 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258496![]() (US10633384, Example 1.18 | US9493486, 1.18) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 625 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258495![]() (US10633384, Example 1.17 | US9493486, 1.17) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 729 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258499![]() (US10633384, Example 1.21 | US9493486, 1.21) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 821 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258531![]() (US10633384, Example 6.10 | US9493486, 6.10) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 826 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258484![]() (US10633384, Example 1.05 | US9493486, 1.05) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258535![]() (US10633384, Example 9 | US9493486, 9) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258559![]() (US10633384, Example 12.21 | US9493486, 12.21) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258537![]() (US10633384, Example 11 | US9493486, 11) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258568![]() (US10633384, Example 12.30 | US9493486, 12.30) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258547![]() (US10633384, Example 12.09 | US9493486, 12.09) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.64E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258561![]() (US10633384, Example 12.23 | US9493486, 12.23) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258557![]() (US10633384, Example 12.19 | US9493486, 12.19) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258480![]() (US10633384, Example 1.01 | US9493486, 1.01) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258524![]() (US10633384, Example 6.3 | US9493486, 6.3) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258526![]() (US10633384, Example 6.5 | US9493486, 6.5) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258487![]() (US10633384, Example 1.08 | US9493486, 1.08) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258536![]() (US10633384, Example 10 | US9493486, 10) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258551![]() (US10633384, Example 12.13 | US9493486, 12.13) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.52E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258511![]() (US10633384, Example 3.1 | US9493486, 3.1) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258489![]() (US10633384, Example 1.10 | US9493486, 1.10) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258546![]() (US10633384, Example 12.08 | US9493486, 12.08) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258528![]() (US10633384, Example 6.7 | US9493486, 6.7) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258486![]() (US10633384, Example 1.07 | US9493486, 1.07) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258543![]() (US10633384, Example 12.05 | US9493486, 12.05) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.98E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258492![]() (US10633384, Example 1.13 | US9493486, 1.13) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258558![]() (US10633384, Example 12.20 | US9493486, 12.20) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.64E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM258544![]() (US10633384, Example 12.06 | US9493486, 12.06) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10633384 (2020) | |||||||||||
More data for this Ligand-Target Pair |